JPMorgan Downgrades Moderna (MRNA) to Neutral on Valuation Following 385% YTD Run-Up
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Moderna (MRNA) Trades Lower after Pfizer (PFE) and BioNTech (BNTX) Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
July 20, 2020 8:47 AM EDTModerna (NASDAQ: MRNA) Trades Lower after Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX) Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
... More